KIMIA BIOSCIENCES Financial Statement Analysis
|
||
The Revenues of KIMIA BIOSCIENCES have decreased by -18.39% YoY .
The Earnings Per Share (EPS) of KIMIA BIOSCIENCES has decreased by Negative YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
KIMIA BIOSCIENCES Last 5 Annual Financial Results
[BOM: 530313]
Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Revenues | ₹105 Cr | ₹129 Cr | ₹125 Cr | ₹133 Cr | ₹106 Cr |
Expenses | ₹105 Cr | ₹134 Cr | ₹124 Cr | ₹124 Cr | ₹102 Cr |
Operating Profit (Excl OI) | ₹-0.48 Cr | ₹-5.09 Cr | ₹0.63 Cr | ₹8.38 Cr | ₹4.45 Cr |
Other Income | ₹1.64 Cr | ₹1.33 Cr | ₹0.93 Cr | ₹2.46 Cr | ₹0.96 Cr |
Interest | ₹5.05 Cr | ₹4.25 Cr | ₹3.64 Cr | ₹3.39 Cr | ₹2.53 Cr |
Depreciation | ₹3.29 Cr | ₹3.33 Cr | ₹2.94 Cr | ₹1.91 Cr | ₹1.66 Cr |
Profit Before Tax | ₹-7.18 Cr | ₹-12 Cr | ₹-5.02 Cr | ₹5.53 Cr | ₹1.23 Cr |
Profit After Tax | ₹-5.31 Cr | ₹-9.35 Cr | ₹-3.70 Cr | ₹5.10 Cr | ₹1.38 Cr |
Earnings Per Share (Rs) | ₹-1.12 | ₹-1.98 | ₹-0.78 | ₹1.08 | ₹0.30 |
PAT Margin (%) | -5.06 | -7.28 | -2.96 | 3.85 | 1.30 |
ROE(%) | -183.25 | -91.91 | -22.22 | 32.19 | 16.47 |
ROCE(%) | -4.18 | -14.30 | -2.32 | 16.13 | 8.94 |
Total Debt/Equity(x) | 131.12 | 9.69 | 2.73 | 2.44 | 2.54 |
Key Financials |
||
Market Cap | : | ₹ 316.9 Cr |
Revenue (TTM) | : | ₹ 111.0 Cr |
Net Profit(TTM) | : | ₹ 9.4 Cr |
EPS (TTM) | : | ₹ 2.0 |
P/E (TTM) | : | 33.6 |
Industry Peers & Returns | 1W | 1M | 1Y |
KIMIA BIOSCIENCES | -6.3% | 39.6% | 34.7% |
SUN PHARMACEUTICAL INDUSTRIES | -0.7% | -1.3% | 6.6% |
DIVIS LABORATORIES | 1.8% | 4.8% | 49.8% |
CIPLA | -1.1% | -1.3% | -1.4% |
TORRENT PHARMACEUTICALS | 0.6% | 4.2% | 15.1% |
DR REDDYS LABORATORIES | -1.8% | -6% | -1.6% |
MANKIND PHARMA | 6.9% | 6.2% | 13.7% |
ZYDUS LIFESCIENCES | -2.1% | -0.3% | -15.4% |
LUPIN | -2.2% | -4.7% | 8.6% |
KIMIA BIOSCIENCES Revenues
[BOM: 530313]
Y-o-Y | -18.39 % |
5 Yr CAGR | -0.33 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹105 Cr | -18.39 | |
Mar2023 | ₹129 Cr | 2.89 | |
Mar2022 | ₹125 Cr | -5.89 | |
Mar2021 | ₹133 Cr | 24.86 | |
Mar2020 | ₹106 Cr | - |
KIMIA BIOSCIENCES Operating Profit
[BOM: 530313]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-0.48 Cr | Negative | |
Mar2023 | ₹-5.09 Cr | Negative | |
Mar2022 | ₹0.63 Cr | -92.47 | |
Mar2021 | ₹8.38 Cr | 88.25 | |
Mar2020 | ₹4.45 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | -0.46% | Negative | |
Mar2023 | -3.96% | Negative | |
Mar2022 | 0.51% | -91.92 | |
Mar2021 | 6.31% | 50.60 | |
Mar2020 | 4.19% | - |
KIMIA BIOSCIENCES Profit After Tax
[BOM: 530313]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹-5.31 Cr | Negative | |
Mar2023 | ₹-9.35 Cr | Negative | |
Mar2022 | ₹-3.70 Cr | Negative | |
Mar2021 | ₹5.10 Cr | 269.59 | |
Mar2020 | ₹1.38 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | -5.06 % | Negative | |
Mar2023 | -7.28 % | Negative | |
Mar2022 | -2.96 % | Negative | |
Mar2021 | 3.85 % | 196.15 | |
Mar2020 | 1.3 % | - |
KIMIA BIOSCIENCES Earnings Per Share (EPS)
[BOM: 530313]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹-1.12 | Negative | |
Mar2023 | ₹-1.98 | Negative | |
Mar2022 | ₹-0.78 | Negative | |
Mar2021 | ₹1.08 | 260.00 | |
Mar2020 | ₹0.30 | - |
KIMIA BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 530313]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | -4.18% | Negative | |
Mar2023 | -14.3% | Negative | |
Mar2022 | -2.32% | Negative | |
Mar2021 | 16.13% | 80.43 | |
Mar2020 | 8.94% | - |
KIMIA BIOSCIENCES Share Price vs Sensex
Current Share Price | : | ₹67.0 |
Current MarketCap | : | ₹ 316.9 Cr |
Updated EOD on | : | Jul 09,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KIMIA BIOSCIENCES | -6.3% |
39.6% |
34.7% |
SENSEX | 0.2% |
1.3% |
4.4% |
KIMIA BIOSCIENCES related INDICES
You may also like the below Video Courses
FAQ about KIMIA BIOSCIENCES Financials
How the annual revenues of KIMIA BIOSCIENCES have changed ?
The Revenues of KIMIA BIOSCIENCES have decreased by -18.39% YoY .
How the Earnings per Share (EPS) of KIMIA BIOSCIENCES have changed?
The Earnings Per Share (EPS) of KIMIA BIOSCIENCES has decreased by Negative YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs